学者信息

黄承浩 (ChengHao Huang)

公共卫生学院

合作者

已发表成果:

WOK 论文 20 篇;中文核心 14 篇;

  • Immune landscape and response to oncolytic virus-based immunotherapy

    FRONTIERS OF MEDICINE,2095-0217,2024-03-08.
    Lin, Chaolong; Teng, Wenzhong; Tian, Yang; Li, Shaopeng; Xia, Ningshao; Huang, Chenghao
    WOS:001178358800001   10.1007/s11684-023-1048-0
    收录情况:SCIE
  • Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1

    NATURE COMMUNICATIONS,,2024-01-02.
    Ren, Wenfeng; Xu, Zilong; Chang, Yating; Ju, Fei; Wu, Hongning; Liang, Zhiqi; Zhao, Min; Wang, Naiz...
    WOS:001158425400070   10.1038/s41467-023-44466-7
    收录情况:SCIE
  • The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,,2023-10-27.
    Wang, Guosong; Cao, Jiali; Gui, Mengxuan; Huang, Pengfei; Zhang, Liang; Qi, Ruoyao; Chen, Ruiqi; Li...
    WOS:001088327200001   10.1186/s13046-023-02848-1
    收录情况:SCIE
  • Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses

    ANTIVIRAL RESEARCH,0166-3542,2022-11.
    Zeng, Yuanjun; Song, Feibo; Luo, Guoxing; Yang, Han; Li, Cao; Liu, Wei; Li, Tingdong; Zhang, Shiyin...
    WOS:000862520100001   10.1016/j.antiviral.2022.105407
    收录情况:SCIE
  • Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

    JOURNAL FOR IMMUNOTHERAPY OF CANCER,,2022-06.
    Ju, Fei; Luo, Yong; Lin, Chaolong; Jia, Xian; Xu, Zilong; Tian, Rui; Lin, Yanhua; Zhao, Min; Chang,...
    WOS:000810551500006   10.1136/jitc-2022-004762
    收录情况:SCIE
  • A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D

    ANTIVIRAL RESEARCH,0166-3542,2022-05.
    Tian, Rui; Ju, Fei; Yu, Mengqin; Liang, Zhiqi; Xu, Zilong; Zhao, Min; Qin, Yaning; Lin, Yanhua; Hua...
    WOS:000821796400004   10.1016/j.antiviral.2022.105298
    收录情况:SCIE
  • Cell osteogenic bioactivity mediated precisely by varying scaled micro-pits on ordered micro/nano hierarchical structures of titanium

    REGENERATIVE BIOMATERIALS,2056-3418,2022-04-08.
    Zhang, Yanmei; Wang, Xiankuan; Li, Yaxian; Liang, Jianhe; Jiang, Pinliang; Huang, Qiaoling; Yang, Y...
    WOS:000826654400002   EI:20224813195661   10.1093/rb/rbac046
    收录情况:SCIE、EI
  • HER2/PD1 bispecific antibody in IgG4 subclass with superior anti-tumour activities

    CLINICAL AND TRANSLATIONAL MEDICINE,2001-1326,2022-04.
    Chu, Wendi; Xu, Hui; Wang, Yanfei; Xie, Yongle; Chen, Yi-Li; Tan, Xiaorong; Huang, Chenghao; Wang, ...
    WOS:000778130600001   10.1002/ctm2.791
    收录情况:SCIE
  • Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

    CANCER IMMUNOLOGY RESEARCH,2326-6066,2020-05.
    Lin, Chaolong; Ren, Wenfeng; Luo, Yong; Li, Shaopeng; Chang, Yating; Li, Lu; Xiong, Dan; Huang, Xia...
    WOS:000531795400006   10.1158/2326-6066.CIR-19-0628
    收录情况:SCIE
  • Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

    ONCOIMMUNOLOGY,2162-402X,2020-01-01.
    Luo, Yong; Lin, Chaolong; Zou, Yidi; Ju, Fei; Ren, Wenfeng; Lin, Yanhua; Wang, Yale; Huang, Xiaoxua...
    WOS:000512840000001   10.1080/2162402X.2020.1726168
    收录情况:SCIE
  • Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma

    MOLECULAR THERAPY-ONCOLYTICS,2372-7705,2019-12-20.
    Luo, Y; Lin, CL; Ren, WF; Ju, F; Xu, ZL; Liu, HL; Yu, Z; Chen, J; Zhang, J; Liu, PG; Huang, CH; Xia...
    WOS:000503785700016   10.1016/j.omto.2019.09.004
    收录情况:SCIE
  • Bibliometric analysis of oncolytic virus research, 2000 to 2018

    MEDICINE,0025-7974,2019-08.
    Zou, YD; Luo, Y; Zhang, J; Xia, NS; Tan, GW; Huang, CH
    WOS:000486239900019   10.1097/MD.0000000000016817
    收录情况:SCIE
  • Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction

    NATURE COMMUNICATIONS,2041-1723,2019-07-19.
    Zhang, TY; Chen, HY; Cao, JL; Xiong, HL; Mo, XB; Li, TL; Kang, XZ; Zhao, JH; Yin, B; Zhao, X; Huang...
    WOS:000476471300001   10.1038/s41467-019-11173-1
    收录情况:SCIE
  • Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer

    Oxidative Medicine and Cellular Longevity,1942-0900,2019.
    Huang, Chenghao (1); Zhang, Yanmei (2, 3); Zhong, Shuping (3); Goncaves, Reggiani Vilela (3)
    WOS:000497334800005   EI:20194707714936   10.1155/2019/4818106
    收录情况:SCIE、EI
  • A novel approach for rapid high-throughput selection of recombinant functional rat monoclonal antibodies

    BMC IMMUNOLOGY,1471-2237,2018-12-04.
    Chen, Q; Qiu, SP; Li, HH; Lin, CL; Luo, Y; Ren, WF; Zou, YD; Wang, YL; Xia, NS; Huang, CH
    WOS:000452129800001   10.1186/s12865-018-0274-8
    收录情况:SCIE
  • ER stress regulating protein phosphatase 2A-B56 gamma, targeted by hepatitis B virus X protein, induces cell cycle arrest and apoptosis of hepatocytes

    CELL DEATH & DISEASE,2041-4889,2018-07-09.
    He, CY; Qiu, Y; Han, PY; Chen, YY; Zhang, LY; Yuan, Q; Zhang, TY; Cheng, T; Yuan, LZ; Huang, CH; Zh...
    WOS:000438367000010   10.1038/s41419-018-0787-3
    收录情况:SCIE
  • Exploring a common mechanism of alcohol-induced deregulation of RNA Pol III genes in liver and breast cells

    GENE,0378-1119,2017-08-30.
    Yi, Yunfeng; Huang, Chenghao; Zhang, Yanmei; Tian, Suke; Lei, Junxia; Chen, Songlin; Shi, Ganggang;...
    WOS:000407404600039   10.1016/j.gene.2017.05.048
    收录情况:SCIE
  • Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells

    SCIENTIFIC REPORTS,2045-2322,2016-10-07.
    Lin, Chaolong; Li, Huanhuan; Hao, Mengru; Xiong, Dan; Luo, Yong; Huang, Chenghao; Yuan, Quan; Zhang...
    WOS:000391998700001   10.1038/srep34531
    收录情况:SCIE
  • Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

    VIROLOGY JOURNAL,1743-422X,2016-03-18.
    Luo, Yong; Xiong, Dan; Li, Huan-Huan; Qiu, Sheng-Ping; Lin, Chao-Long; Chen, Qin; Huang, Cheng-Hao;...
    WOS:000372443000001   10.1186/s12985-016-0508-4
    收录情况:SCIE
  • Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction

    Proceedings of the National Academy of Sciences of the United States of America,0027-8424,2012-11-06.
    Geng, Xin; Huang, Chenghao; Qin, Yan; McCombs, Janet E.; Yuan, Quan; Harry, Brian L.; Palmer, Amy E...
    WOS:000311156700054   10.1073/pnas.1204668109
    收录情况:SCIE
  • 巨噬细胞极化中糖代谢重编程的研究进展

    中国病理生理杂志,1000-4718,2023-09-25.
    吴红宁;林超龙;黄承浩
    CSCD核心库
  • RNA药物递送载体的研究进展

    生命科学,1004-0374,2023-08-15.
    娄瑞;林超龙;黄承浩
    CSCD核心库
  • ANGPTL2在肿瘤发生发展中的作用及调控机制的研究进展

    生命科学,1004-0374,2022-06-15.
    李路;黄承浩
    CSCD核心
  • 肿瘤代谢对免疫细胞的影响

    生命科学,1004-0374,2022-05-15.
    赵敏;黄承浩
    CSCD核心
  • 溶瘤病毒在神经胶质瘤治疗中的研究进展

    生命科学,1004-0374,2020-07-31.
    陈珺;黄承浩
    CSCD扩展
  • 脂质代谢调节肿瘤细胞铁死亡研究进展

    生命科学,1004-0374,2020-07-15.
    余增;黄承浩
    CSCD扩展
  • 溶瘤病毒疗法在胰腺癌治疗中的研究进展

    生命科学,1004-0374,2020-02-29.
    刘惠玲;黄承浩
    CSCD扩展
  • 胰腺导管腺癌面临的挑战与最新研究进展

    生命科学,1004-0374,2019-09-15.
    邹依地;黄承浩
    CSCD核心
  • 谷氨酰胺转运载体ASCT2在肿瘤中的研究进展

    肿瘤防治研究,1000-8578,2019-01-24.
    王雅乐;黄承浩
    CSCD核心
  • 基于CRISPR-Cas9的功能基因筛选研究进展

    生物工程学报,1000-3061,2018.
    李欢欢;黄承浩
    CSCD核心
  • 肝细胞癌靶向治疗最新研究进展

    生命科学,1004-0374,2018.
    邱盛萍;黄承浩
    CSCD核心
  • 溶瘤病毒联合小分子抑制剂应用于肿瘤治疗的研究进展

    病毒学报,1000-8721,2017.
    陈琴;黄承浩;夏宁邵
    CSCD核心
  • 溶瘤病毒与肿瘤治疗

    生命科学,1004-0374,2016-10-11.
    潘海娇;陈琴;黄承浩;夏宁邵
    CSCD扩展 CSCD扩展 理工二类核心
  • HSV-1溶瘤病毒在肿瘤治疗研究中的新进展

    病毒学报,1000-8721,2016-06-30.
    郝蒙茹;黄承浩;夏宁邵
    CSCD核心 CSCD核心